- Home
- LTBR vs ABEO Comparison
LTBR vs ABEO Comparison
Compare LTBR & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTBR
- ABEO
- Stock Information
- Founded
- LTBR 1992
- ABEO 1974
- Country
- LTBR United States
- ABEO United States
- Employees
- LTBR N/A
- ABEO N/A
- Industry
- LTBR Professional Services
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- LTBR Consumer Discretionary
- ABEO Health Care
- Exchange
- LTBR Nasdaq
- ABEO Nasdaq
- Market Cap
- LTBR 397.8M
- ABEO 332.0M
- IPO Year
- LTBR N/A
- ABEO 1980
- Fundamental
- Price
- LTBR $15.13
- ABEO $6.83
- Analyst Decision
- LTBR
- ABEO Strong Buy
- Analyst Count
- LTBR 0
- ABEO 6
- Target Price
- LTBR N/A
- ABEO $18.17
- AVG Volume (30 Days)
- LTBR 1.5M
- ABEO 702.3K
- Earning Date
- LTBR 08-11-2025
- ABEO 08-14-2025
- Dividend Yield
- LTBR N/A
- ABEO N/A
- EPS Growth
- LTBR N/A
- ABEO N/A
- EPS
- LTBR N/A
- ABEO 0.99
- Revenue
- LTBR N/A
- ABEO $400,000.00
- Revenue This Year
- LTBR N/A
- ABEO N/A
- Revenue Next Year
- LTBR N/A
- ABEO $339.63
- P/E Ratio
- LTBR N/A
- ABEO $6.91
- Revenue Growth
- LTBR N/A
- ABEO N/A
- 52 Week Low
- LTBR $2.24
- ABEO $3.93
- 52 Week High
- LTBR $18.80
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- LTBR 52.17
- ABEO 52.71
- Support Level
- LTBR $12.93
- ABEO $6.70
- Resistance Level
- LTBR $16.19
- ABEO $7.15
- Average True Range (ATR)
- LTBR 1.48
- ABEO 0.31
- MACD
- LTBR -0.02
- ABEO -0.02
- Stochastic Oscillator
- LTBR 37.48
- ABEO 46.62
About LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.